Coya Therapeutics, Inc.
COYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $87,319 | $75,315 | $12,272 | $44,233 |
| - Cash | $38,340 | $32,627 | $5,934 | $4,340 |
| + Debt | $0 | $0 | $12,965 | $0 |
| Enterprise Value | $48,980 | $42,688 | $19,303 | $39,893 |
| Revenue | $3,554 | $6,002 | $0 | $0 |
| % Growth | -40.8% | – | – | – |
| Gross Profit | -$8,312 | $501 | -$4,412 | $0 |
| % Margin | -233.9% | 8.3% | – | – |
| EBITDA | -$17,197 | -$7,333 | -$9,260 | -$4,854 |
| % Margin | -483.9% | -122.2% | – | – |
| Net Income | -$14,881 | -$7,988 | -$12,245 | -$4,892 |
| % Margin | -418.7% | -133.1% | – | – |
| EPS Diluted | -0.98 | -0.79 | -1.231 | -0.74 |
| % Growth | -24.1% | 35.8% | -66.3% | – |
| Operating Cash Flow | -$10,289 | -$11,189 | -$7,239 | -$3,903 |
| Capital Expenditures | $0 | $0 | $0 | -$137 |
| Free Cash Flow | -$10,289 | -$11,189 | -$7,239 | -$4,040 |